Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group Study POG 9421.
M M
MM
O'Brien
X
X
Cao
S
S
Pounds
G V
GV
Dahl
S C
SC
Raimondi
N J
NJ
Lacayo
J
J
Taub
M
M
Chang
H J
HJ
Weinstein
Y
Y
Ravindranath
H
H
Inaba
D
D
Campana
C H
CH
Pui
J E
JE
Rubnitz
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D020732:Cytogenetic Analysis; D004314:Down Syndrome / Q000150:complications* / Q000235:genetics / Q000401:mortality; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007947:Leukemia, Megakaryoblastic, Acute / Q000209:etiology* / Q000401:mortality / Q000473:pathology; D008297:Male; D018365:Neoplasm, Residual / Q000175:diagnosis* / Q000235:genetics / Q000401:mortality; D011379:Prognosis; D011446:Prospective Studies; D015996:Survival Rate; D055815:Young Adult